Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies

被引:146
|
作者
van den Berg, JG
Weerman, MAV
Assmann, KJM
Weening, JJ
Florquin, S
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Med Ctr Nijmegen, Dept Pathol, Nijmegen, Netherlands
关键词
podocyte; foot process effacement; proteinuria; minimal change nephrotic syndrome; glomerular visceral epithelial cell; electron microscopy;
D O I
10.1111/j.1523-1755.2004.00964.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Nephrotic syndromes result from increased glomerular permeability to proteins and are structurally believed to be associated with podocyte foot process effacement. Despite increasing knowledge of the molecular composition of the glomerular filtration barrier, the relationship between proteinuria and foot process effacement is unclear. Methods. We conducted a morphologic study on the relationship between podocyte foot process effacement and proteinuria. Electron microscope pictures of glomerular capillaries were randomly taken from 27 cases in various stages of minimal change nephrotic syndrome (MCNS), from six cases of IgA nephropathy (IgAN) with high proteinuria and from seven control kidneys. From each picture, the mean width of the foot processes (FPW) was quantitated. Results. In normal kidney the mean FPW was 580 +/- 40 nm. In biopsies from patients with MCNS without treatment, foot processes were diffusely effaced, reflected by a FPW of 1600 +/- 440 nm. In biopsies from patients with MCNS relapsing under prednisolone treatment, foot processes were significantly less effaced than in untreated MCNS (FPW 920 +/- 200 nm). In biopsies displaying IgAN, effacement was significantly more segmental than in untreated MCNS (FPW 800 +/- 170 nm). Proteinuria did not differ significantly among the groups. Neither in MCNS nor in IgAN was the extent of foot process effacement correlated with the level of proteinuria. Conclusion. Podocyte foot process effacement is not correlated with proteinuria. The differences in podocyte effacement between MCNS, MCNS relapsing under prednisolone treatment, and IgAN may point to different mechanisms of podocyte injury in these diseases.
引用
收藏
页码:1901 / 1906
页数:6
相关论文
共 50 条
  • [41] B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement
    Kim, Alfred H. J.
    Chung, Jun-Jae
    Akilesh, Shreeram
    Koziell, Ania
    Jain, Sanjay
    Hodgin, Jeffrey B.
    Miller, Mark J.
    Stappenbeck, Thaddeus S.
    Miner, Jeffrey H.
    Shaw, Andrey S.
    JCI INSIGHT, 2017, 2 (21):
  • [42] Interaction of Shroom3 With Fyn Impacts Phosphorylation of Nephrin Causing Proteinuria With Foot Process Effacement.
    Menon, Madhav C.
    Philippe, Nimrod
    Wei, Chengguo
    Liu, Ruijie
    Zhang, Weijia
    Li, Zhengzi
    He, John C.
    Murphy, Barbara
    HYPERTENSION, 2017, 70
  • [43] Podocyte-Specific Knockdown of SHROOM3 Causes Albuminuria and Foot-Process Effacement by Interaction with FYN
    Menon, M.
    Philippe, N.
    Wei, C.
    Zhang, W.
    He, J.
    Murphy, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 317 - 317
  • [44] Association of FOS-Like Antigen 1 Promoter Polymorphism with Podocyte Foot Process Effacement in Immunoglobulin A Nephropathy Patients
    Park, Hae Jeong
    Kim, Jong Woo
    Cho, Byoung-Soo
    Chung, Joo-Ho
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (05) : 391 - 397
  • [45] Podocyte Foot Process Effacement Precedes Albuminuria and Glomerular Hypertrophy in CD2-Associated Protein Deficient Mice
    Basgen, John M.
    Wong, Jenny S.
    Ray, Justina
    Nicholas, Susanne B.
    Campbell, Kirk N.
    FRONTIERS IN MEDICINE, 2021, 8
  • [46] Inhibitory effects of eucalyptol on diabetes-associated loss of glomerular slit junctions and podocyte foot process effacement.
    Kim, D.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [47] Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement
    Angelina Schwarz
    Katja Möller-Hackbarth
    Lwaki Ebarasi
    David Unnersjö Jess
    Sonia Zambrano
    Hans Blom
    Annika Wernerson
    Mark Lal
    Jaakko Patrakka
    Scientific Reports, 9
  • [48] Coro2b, a podocyte protein downregulated in human diabetic nephropathy, is involved in the development of protamine sulphate-induced foot process effacement
    Schwarz, Angelina
    Moller-Hackbarth, Katja
    Ebarasi, Lwaki
    Jess, David Unnersjo
    Zambrano, Sonia
    Blom, Hans
    Wernerson, Annika
    Lel, Mark
    Patrakka, Jaakko
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [49] Author Correction: FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy
    Szu-Yuan Li
    Pao-Hsien Chu
    Po-Hsun Huang
    Tsung-Han Hsieh
    Katalin Susztak
    Der-Cherng Tarng
    Scientific Reports, 9
  • [50] Uncovering the Podocyte Foot Process Proteome
    Gerlach, Gary F.
    O'Brien, Lori L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 228 - 228